Veradigm (NASDAQ:MDRX) Earns Hold Rating from Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a research note issued on Monday. The firm set a “hold” rating on the software maker’s stock.

Veradigm Trading Down 2.9 %

NASDAQ MDRX opened at $9.42 on Monday. Veradigm has a 52 week low of $5.01 and a 52 week high of $14.09. The firm has a 50 day moving average of $9.65 and a two-hundred day moving average of $8.95.

Institutional Trading of Veradigm

A number of institutional investors have recently bought and sold shares of the business. Campbell & CO Investment Adviser LLC increased its holdings in shares of Veradigm by 5.7% in the 4th quarter. Campbell & CO Investment Adviser LLC now owns 42,113 shares of the software maker’s stock valued at $442,000 after acquiring an additional 2,263 shares during the last quarter. Innealta Capital LLC acquired a new position in Veradigm in the second quarter valued at approximately $38,000. TFO Wealth Partners LLC increased its stake in Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after purchasing an additional 5,264 shares during the last quarter. Meadow Creek Wealth Advisors LLC acquired a new stake in Veradigm during the first quarter worth approximately $83,000. Finally, Forest Hill Capital LLC purchased a new stake in shares of Veradigm during the 4th quarter worth approximately $210,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.